We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Real-Time PCR Of Oropharyngeal Swabs Diagnoses Pneumonia in Adults

By LabMedica International staff writers
Posted on 13 Dec 2016
A lack of sensitive tests and difficulties obtaining representative samples contribute to the challenge in identifying etiology in pneumonia. More...
Upper respiratory tract swabs can be easily collected and analyzed with real-time polymerase chain reaction (rtPCR).

The microbial etiology of pneumonia often remains undetected despite extensive diagnostic testing. Blood cultures lack sensitivity and obtaining representative lower respiratory tract samples can be challenging. An etiologic diagnosis allows targeted antimicrobial treatment, a matter of increasing importance as resistance rates increase.

Medical scientists at the University of Iceland (Reykjavik, Iceland) prospectively collected oropharyngeal swabs from 239 adults admitted to hospital with pneumonia. Blood cultures were collected, incubated and cultured using standard methods. Urine antigen testing (UAT) for Streptococcus pneumoniae (SP) was performed using a commercially available kit, the BinaxNOW Streptococcus pneumoniae (Alere, Waltham, MA, USA). An oropharyngeal swab sample using sterile rayon tipped swabs, (COPAN Italia, Brescia, Italy) was collected for rtPCR.

The team extracted nucleic acid from 200 μL specimens and rtPCR was performed with an ABI 7900 384-well system (Applied Biosystems, Foster City, CA, USA). The specificity of rtPCR for SP and Haemophilus influenzae (HI) was tested using reference samples containing S. mitis, S. oralis and S. sanguinis, and H. haemolyticus and H. parainfluenzae respectively. No cross-reaction was noted with either comparison. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of rtPCR for SP and HI were calculated using combined and separate results from sputum (SP and HI) and blood cultures (SP only), and urine antigen analysis (SP only) as a reference “gold standard”.

When the investigators compared the rtPCR with conventional testing for S. pneumoniae in 57 patients with all tests available, this resulted in a sensitivity of 87 %,a specificity of 79 %, PPV equalled 59 % and the NPV was 94 %, and for 67 H. influenzae patients, the sensitivity was, 75 %, specificity 80 %, PPV 45 % and NPV 94 %. When patients with prior antimicrobial exposure were excluded sensitivity improved: 92 % for S. pneumoniae and 80 % for H. influenzae. Receiver operating characteristic curve analysis demonstrated for S. pneumoniae: AUC = 0.65 and for H. influenzae: AUC = 0.86. Using rtPCR SP was identified in 61 (25.5 %) cases and HI in 50 (20.9 %).

The authors concluded that analysis of oropharyngeal swabs using rtPCR proved both reasonably sensitive and specific for diagnosing pneumonia caused by S. pneumoniae and H. influenzae. This method may be a useful diagnostic adjunct to other methods and of special value in patients unable to provide representative lower airway samples. The study was published online on November 7, 2016, in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:
University of Iceland
Alere
COPAN Italia
Applied Biosystems

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.